Introduction {#sec1}
============

Allylic esters have garnered increasing attention because of their presence in bioactive and medicinally relevant molecules.^[@ref1]^ They are widely present in bioactive natural products such as grandiuvarone A and albanol A ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), which are isolated from the barks of *Uvaria grandiflora* and *Uvaria alba*, respectively, and are known to exhibit antileishmanial, cytostatic, and antiproliferative activities. Furthermore, branched allylic alcohols and their ester derivatives are important building blocks in organic synthesis.^[@ref2]^

![Bioactive molecules comprising the allylic ester unit.](ao9b02712_0001){#fig1}

Traditional synthetic methods for the preparation of allyl esters involve the reaction of an acid or its derivatives (acyl chlorides and anhydrides) with the corresponding allylic alcohols.^[@ref3]^ However, these approaches suffer from limited substrate scope and harsh reaction conditions. The transition-metal-catalyzed direct oxidative esterification of allylic sp^3^ C--H bonds has emerged as one of the most important strategies for the synthesis of branched allylic esters and is an important alternative to the traditional synthetic approaches. Several methodologies relying on this approach have been reported for the synthesis of allylic esters. Although palladium-,^[@ref4]^ copper-,^[@ref5]^ and iron-catalyzed^[@ref6]^ esterifications of allylic sp^3^ C--H bonds have been reported, they suffer from poor atom economy because of the necessity for the use of stoichiometric equivalents of oxidants. An elegant alternate approach for the synthesis of allylic esters via a redox-neutral and atom-economic rhodium-catalyzed coupling of terminal alkynes with carboxylic acids has been reported recently.^[@ref7]^ Allenes are an easily accessible and remarkably stable substrate class, and Yamamoto,^[@ref8]^ Krische,^[@ref9]^ and Breit^[@ref10]^ reported the palladium-, iridium-, and rhodium-catalyzed coupling of allenes with carboxylic acids for synthesizing linear and branched allylic esters. Although these methods are powerful synthetic transformations, they require the use of transition metals, and in many cases the corresponding ligands in the catalytic system, which make them expensive and less ecofriendly. Considering these wide arrays of available approaches, a metal-free approach to allylic sp^3^ C--H bond esterification would obviate many of the aforementioned disadvantages. However, reports on such metal-free allylic sp^3^ C--H esterification are limited, and only one example using Bu~4~NI as a catalyst was reported,^[@ref11]^ which further highlights the necessity for the development of a straightforward and low-cost metal-free allylic sp^3^ C--H esterification protocol.

Allenamides have recently emerged as important synthetic intermediates and participate in diverse and interesting transformations.^[@ref12]^ We have reported the halogen-mediated intermolecular coupling reactions of allenamides^[@ref13]^ and recently reported a related methodology for the metal-free synthesis of allylic ethers by the regioselective alkoxylation of allenamides with alcohols ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a).^[@ref14]^ However, this reaction required the use of low-boiling alcohol nucleophiles as the reaction solvents, which limited the substrate scope for the transformation and promoted us to examine the allylic substitution using carboxylic acids as the nucleophiles. We present herein a metal-free synthesis of branched allylic esters with broad functional group tolerance by the *N*-iodosuccinimide (NIS)-mediated regioselective acyloxylation at the proximal carbon of allenamides ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b).

![NIS-Mediated Regioselective Alkoxylation and Acyloxylation of Allenamides](ao9b02712_0004){#sch1}

Results and Discussion {#sec2}
======================

On the basis of our previous results on the regioselective 1,2-additions of alcohols to allenamides, we began our studies by exploring the reaction between phenyl allenamide **1a** and acetic acid **2a**, and the optimization results of the study are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Employing the conditions from our previous study, upon treating phenyl allenamide **1a** with 1.05 equiv of NIS in 3 mL of acetic acid, the acyloxylated product **4aa** was isolated in 86% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). When the reaction was performed with 1 equiv of acetic acid **2a** in 3 mL of dichloromethane (DCM), the branched allylic ester **4aa** was obtained in 52% yield along with the linear allylic ester **5a** in 20% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2). In an attempt to increase the nucleophilicity of acetic acid **2a**, 2 equiv of K~2~CO~3~ was added to the reaction mixture, which delivered the branched allylic ester in 27% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). After screening various equivalent ratios of **1a** and **2a**, we found that the best regioselectivity and yield of the branched allylic ester **4a** were obtained with the use of 6 equiv of **2a** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Various iodine sources were evaluated next, and compared to other iodine sources such as *N*-iodophthalimide (**3d**) and elemental iodine (**3g**), NIS proved to be the best choice for generating the target compound **4aa**. Encouraged by these results, we examined the related *N*-haloimides for this transformation. When *N*-bromosuccinimide (**3b**) and *N*-bromophthalimide (**3e**) were used in this reaction, the branched allylic ester **4b** was isolated in 50 and 47% yields, respectively ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 5 and 8). *N*-Chlorosuccinimide (**3c**) and *N*-chlorophthalimide (**3f**) were less reactive and delivered the corresponding product **4c** in 55 and 34% yields, respectively. Subsequent solvent screening studies indicated an increase in the yield of **4aa** to 85% when CH~3~CN was used as the solvent, whereas 1,2-dichloroethane (DCE), CHCl~3~, toluene, and acetone were not as effective under the reaction conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11--15). Furthermore, the control experiment ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 16) showed that no acyloxylated product was obtained in the absence of NIS, revealing the importance of the iodine sources.

![Optimization of **1a**/**2a** equiv ratio.](ao9b02712_0002){#fig2}

###### Optimization of Halogen-Mediated Acyloxylation of Allenamide **1a** with Acetic Acid **2a**[a](#t1fn1){ref-type="table-fn"}

![](ao9b02712_0006){#GRAPHIC-d7e408-autogenerated}

  entry                               **1a**/**2a**   halogen reagent   solvent       yield **4**/**5** (%)
  ----------------------------------- --------------- ----------------- ------------- -----------------------
  1[b](#t1fn2){ref-type="table-fn"}                   **3a**            acetic acid   86/0
  2                                   1/1             **3a**            DCM           52/20
  3[c](#t1fn3){ref-type="table-fn"}   1/1             **3a**            DCM           27/0
  4[d](#t1fn4){ref-type="table-fn"}   1/6             **3a**            DCM           79/7
  5                                   1/6             **3b**            DCM           50/12
  6[e](#t1fn5){ref-type="table-fn"}   1/6             **3c**            DCM           55/22
  7[f](#t1fn6){ref-type="table-fn"}   1/6             **3d**            DCM           38/0
  8                                   1/6             **3e**            DCM           47/0
  9                                   1/6             **3f**            DCM           34/0
  10                                  1/6             **3g**            DCM           trace
  11                                  1/6             **3a**            DCE           62/16
  12                                  1/6             **3a**            CHCl~3~       69/23
  13                                  1/6             **3a**            CH~3~CN       85/0
  14                                  1/6             **3a**            toluene       69/5
  15                                  1/6             **3a**            acetone       77/10
  16                                  1/6                               CH~3~CN       NR

Unless stated otherwise, all reactions were carried out with **1a** (0.1 mmol) and **3** (0.105 mmol) in 3 mL of solvent at rt and are complete within 5 min.

The reaction was carried out with 3 mL of acetic acid as the solvent.

1.1 equiv K~2~CO~3~ was added.

Best ratio of **1a**/**2a** equiv.

**1a** was consumed within 1.5 h.

**1a** was consumed within 9 h.

Employing the optimized conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13), we investigated the scope of the carboxylic acid substrates in the reaction ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) and were pleased to find the efficient formation of the desired products in good yields for all acids which were evaluated. Aliphatic carboxylic acids (linear and branched) worked well and afforded the desired allylic esters (**4aa--4ae**) in 62--85% yields. Similarly, cyclic carboxylic acids afforded the branched allylic esters (**4af--4ai**) in 63--84% yields. Furthermore, the sterically hindered adamantyl carboxylic acid **2j** was a suitable substrate and furnished the corresponding product in 63% yield. In addition to the unsubstituted benzoic acid **2k**, both electron-rich and electron-poor aromatic carboxylic acids were suitable reaction partners (**4al--4ap**). The 2-methyl- and 3-fluoro-substituted benzoic acids also provided the corresponding products **4aq** and **4ar** in 68% yield, respectively. The 2-naphthyl carboxylic acid **2s** and cinnamic acid **2t** were also tolerated under the reaction conditions and afforded the desired allylic esters in 72 and 69% yields, respectively.

###### NIS-Mediated Acyloxylation of Allenamide **1a** with Various Carboxylic Acids[a](#t2fn1){ref-type="table-fn"}

![](ao9b02712_0007){#GRAPHIC-d7e859-autogenerated}

![](ao9b02712_0008){#gr6}

Conditions: **1a** (0.1 mmol), **2a** (0.6 mmol), NIS (0.105 mmol), CH~3~CN (3 mL), rt, within 5 min.

Having studied the scope of the carboxylic acids in this reaction, we turned our attention to the investigation of the allenamide scope ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Several *para*- and *meta*-substituted phenyl allenamides were investigated first (**1b--1h**). Phenyl allenamides bearing electron-rich substituents worked better in this reaction and afforded the desired allylic esters **4ba** and **4ca** in 89 and 81% yields, respectively. The initial step of this reaction was proposed to be the electrophilic halogenation between the iodine electrophile and the π system of the allenamide. The reactions with 3,5-dimethoxyl- and 2-naphthyl-substituted allenamides **1i** and **1j** proceeded smoothly and provided **4ia** and **4ja** in 72 and 78% yields, respectively. Moreover, the molecular structure of the branched allylic ester **4ia** was unambiguously determined by single-crystal X-ray diffraction ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).^[@ref15]^ Interestingly, when trimethyl phenyl allenamide was used as the reactant, the linear allylic ester was isolated as the sole product in 56% yield, possibly because of the increased steric hindrance of the substrate. Next, benzyl allenamides **1k--1p** were employed as substrates under optimized reaction conditions, and the *para*-methyl- and bromo-substituted benzyl allenamide **1l** and **1p** gave the allylic esters **4la** and **4pa** in 91 and 84% yields, respectively. Both electron-rich and electron-poor benzyl allenamides **1k** and **1m--1o** furnished the desired products in about 70% yields, exhibiting no obvious substituent effects. We investigated next the reactivity of different allenamides bearing aliphatic substituents under the optimized conditions. Both phenethyl- and *n*-butyl-substituted allenamides produced products **4qa** and **4ra** in 72 and 48% yields, respectively. The reaction was also efficient when the tosyl group in the allenamides was substituted with the acyl and mesyl amino protecting groups and delivered **4sa** and **4ta** in 74 and 81% yields, respectively. Furthermore, 2-oxazolidinone allenamide **1u** also provided the corresponding product **4ua** in 48% yield.

![X-ray structure of **4ia**.](ao9b02712_0003){#fig3}

###### NIS-Mediated Acyloxylation of Various Allenamides **1** with Acetic Acid **2a**[a](#t3fn1){ref-type="table-fn"}

![](ao9b02712_0009){#GRAPHIC-d7e989-autogenerated}

![](ao9b02712_0010){#gr7}

Conditions: **1a** (0.1 mmol), **2a** (0.6 mmol), NIS (0.105 mmol), CH~3~CN (3 mL), rt, within 5 min.

To establish the practicality of this reaction, a gram-scale synthesis of the branched allylic ester **4aa** was carried out. When 1.42 g of allenamide **1a** (5.0 mmol) was used, 1.95 g of the desired product **4aa** was obtained in 83% yield within 5 min, indicating the facile scalability of the transformation to the gram scale without loss in efficiency ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). To further demonstrate the potential applications of this protocol, **1a** was reacted with *N*-Boc-[l]{.smallcaps}-Phe, *N*-Ac-[l]{.smallcaps}-Phe, and *N*-Boc-[l]{.smallcaps}-Tyr, upon which the corresponding products 6, 7, and 8 were isolated in moderate yields in a 1:1 dr.

![Gram-Scale Synthesis and Synthetic Applications](ao9b02712_0005){#sch2}

In summary, we demonstrated the first intermolecular addition of carboxylic acids to the proximal carbon of allenamides toward the formation of highly useful branched allylic esters under superior regioselectivity by employing a simple and commercially available iodine reagent. This reaction proceeds rapidly, is scalable up to a gram scale, and tolerates a broad scope of substrates. Notably, the protected amino acids were compatible and furnished the desired allylic amino acid esters in moderate yields. A further exploration of potential applications and studies to extend this interesting synthetic methodology is currently underway.

Experimental Section {#sec3}
====================

General Conditions {#sec3.1}
------------------

All reactions were performed using Schlenk tubes, septa, and syringes without the protection of nitrogen. Tetrahydrofuran, toluene, DCM, and DCE were freshly distilled over sodium/benzophenone and calcium hydride, respectively. Commercial reagents were used as supplied or were purified by standard techniques where necessary. Column chromatography was performed using a 200--300 mesh silica gel (Qingdao Haiyang Chemical Co., Ltd., silica gel F254) with an appropriate solvent system, as determined by thin-layer chromatography (TLC) analysis using UV light and KMnO~4~ stain to visualize the reaction components. Melting points were determined using a WRS-1B digital melting point instrument. IR spectra were recorded on a Nicoletisso Fourier transform infrared spectrometer using KBr disks. Unless otherwise noted, nuclear magnetic resonance spectra were recorded at room temperature on an Agilent 400 MHz spectrometer using CDCl~3~ as the solvent and tetramethylsilane (TMS) as the internal reference. Chemical shifts for ^13^C nuclear magnetic resonance (NMR) spectra were recorded in parts per million relative to TMS using the central peak of deuterochloroform (77.0 ppm) as the internal standard (see Supporting Information). High-resolution mass spectrometry (HRMS) was performed using a Bruker Daltonics Bio time-of-flight (TOF) mass spectrometer.

Allenamides **1a--1u** were prepared according to the published methods.^[@ref16]^ Carboxylic acids were obtained commercially and used without further purification.

General Procedure for NIS-Mediated Acyloxylation of Allenamide **1a** with Acetic Acid **2a** {#sec3.2}
---------------------------------------------------------------------------------------------

To a Schlenk tube were added allenamide **1a** (0.1 mmol, 28.5 mg), acetic acid **2a** (6.0 equiv, 34 μL), NIS (1.05 equiv, 23.5 mg), and CH~3~CN (anhydrous, 3 mL). Then, the reaction mixture was stirred at room temperature (rt) for 5 min until the complete consumption of the starting material as monitored by TLC. The mixture was then washed with saturated sodium bicarbonate solution (5 mL), extracted with DCM (3 mL × 2), and dried over anhydrous Na~2~SO~4~. The concentration of the reaction mixture in vacuo followed by purification through flash chromatography on a silica gel column (hexane/EtOAc = 5/1 as the eluent) afforded **4aa** (40.0 mg, 85% yield) as a white solid.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Acetate (**4aa**) {#sec3.2.1}

Yield 85% (40.0 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 103.6--108.2 °C; IR (neat, cm^--1^): 3452, 1660, 1630, 1170, 1090, 745, 702; ^1^H NMR (400 MHz, CDCl~3~): δ 7.52 (d, *J* = 8.1 Hz, 2H), 7.36 (t, *J* = 7.1 Hz, 1H), 7.31 (d, *J* = 7.7 Hz, 2H), 7.26--7.24 (m, 5H), 6.03 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 1.99 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 144.0, 136.1, 134.5, 131.5, 129.2, 129.1, 128.9, 128.6, 128.1, 101.2, 84.9, 21.6, 20.6; HRMS (ESI) *m*/*z*: calcd for C~18~H~18~INO~4~SNa^+^ (M + Na)^+^, 493.9893; found, 493.9899.

### 2-Bromo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Acetate (**4b**) {#sec3.2.2}

Yield 50% (21.2 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 120.5--120.9 °C; IR (neat, cm^--1^): 3468, 2935, 2378, 1760, 1365, 1249, 1170, 1088, 700, 666; ^1^H NMR (400 MHz, CDCl~3~): δ 7.43 (d, *J* = 7.9 Hz, 2H), 7.28--7.23 (m, 1H), 7.22--7.12 (m, 5H), 7.10 (d, *J* = 7.5 Hz, 2H), 5.45 (s, 1H), 5.32 (s, 1H), 2.33 (s, 3H), 1.90 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 144.0, 136.2, 134.5, 131.4, 129.3, 129.2, 128.6, 128.0, 125.0, 120.5, 82.9, 21.6, 20.6. HRMS (ESI) *m*/*z*: calcd for C~18~H~18~BrNO~4~SNa^+^ (M + Na)^+^, 446.0032: found, 446.0038.

### 2-Chloro-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Acetate (**4c**) {#sec3.2.3}

Yield 55% (20.8 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 103.4--104.3 °C; IR (neat, cm^--1^): 3480, 2935, 2376, 1761, 1353, 1167, 1091, 700, 667; ^1^H NMR (400 MHz, CDCl~3~): δ 7.44 (d, *J* = 8.2 Hz, 2H), 7.26 (t, *J* = 7.3 Hz, 1H), 7.19 (t, *J* = 7.5 Hz, 2H), 7.15 (d, *J* = 8.9 Hz, 3H), 7.07 (d, *J* = 7.6 Hz, 2H), 5.09 (s, 1H), 5.02 (s, 1H), 2.33 (s, 3H), 1.91 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 144.0, 136.3, 134.5, 134.4, 131.4, 129.3, 129.2, 128.6, 128.0, 116.0, 81.8, 21.6, 20.7. HRMS (ESI) *m*/*z*: calcd for C~18~H~18~Cl~4~SNa^+^ (M + Na)^+^, 402.0537; found, 402.0540.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Propionate (**4ab**) {#sec3.2.4}

Yield 77% (37.5 mg); *R*~*f*~ = 0.31 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 117.7--118.7 °C; IR (neat, cm^--1^): 3463, 2938, 2383, 1642, 1360, 1081, 745; ^1^H NMR (400 MHz, CDCl~3~): δ 7.45 (d, *J* = 7.7 Hz, 2H), 7.31--7.27 (m, 1H), 7.24 (d, *J* = 7.4 Hz, 2H), 7.21--7.16 (m, 5H), 5.94 (s, 1H), 5.64 (s, 1H), 2.36 (s, 3H), 2.24--2.10 (m, 2H), 1.03 (t, *J* = 7.5 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.4, 144.0, 136.2, 134.5, 131.5, 129.3, 129.1, 128.8, 128.5, 128.1, 101.4, 84.7, 27.3, 21.6, 8.7; HRMS (ESI) *m*/*z*: calcd for C~19~H~20~INO~4~SNa^+^ (M + Na)^+^, 508.0050; found, 508.0051.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Butyrate (**4ac**) {#sec3.2.5}

Yield 67% (33.5 mg); *R*~*f*~ = 0.12 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 97.7--99.1 °C; IR (neat, cm^--1^): 3453, 1646, 1271, 1168, 745, 705; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 7.9 Hz, 2H), 7.38--7.34 (m, 1H), 7.31 (d, *J* = 7.6 Hz, 2H), 7.27 (m, 4H), 7.24 (s, 1H), 6.01 (s, 1H), 5.71 (s, 1H), 2.43 (s, 3H), 2.20 (dd, *J* = 16.1, 8.0 Hz, 2H), 1.61 (dd, *J* = 14.7, 7.3 Hz, 2H), 0.94 (t, *J* = 7.3 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 170.7, 144.0, 136.2, 134.5, 131.5, 129.3, 129.1, 128.8, 128.5, 128.1, 101.5, 84.7, 35.7, 21.6, 18.00, 13.7; HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~4~SNa^+^ (M + Na)^+^, 522.0206; found, 522.0209.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Isobutyrate (**4ad**) {#sec3.2.6}

Yield 62% (30.7 mg); *R*~*f*~ = 0.5 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 101.7--102.0 °C; IR (neat, cm^--1^): 3432, 3141, 1647, 1625, 1406, 1075, 600, 574; ^1^H NMR (400 MHz, CDCl~3~): δ 7.54 (d, *J* = 8.2 Hz, 2H), 7.39--7.35 (m, 1H), 7.31 (t, *J* = 7.4 Hz, 2H), 7.27--7.23 (m, 4H), 6.00 (s, 1H), 5.71 (s, 1H), 2.46 (q, *J* = 7.0 Hz), 2.42 (s, 3H), 1.13 (s, 3H), 1.11 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 173.9, 144.0, 136.3, 134.5, 131.6, 129.3, 129.1, 128.7, 128.6, 128.1, 101.7, 84.6, 33.8, 21.6, 18.7, 18.5; HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~4~SNa^+^ (M + Na)^+^, 522.0206; found, 522.0208.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Nonanoate (**4ae**) {#sec3.2.7}

Yield 66% (37.5 mg); *R*~*f*~ = 0.55 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 96.2--97.5 °C; IR (neat, cm^--1^): 3463, 2937, 2372, 2350, 1757, 1172, 1079, 744, 672; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 7.7 Hz, 2H), 7.35 (d, *J* = 6.5 Hz, 1H), 7.31 (d, *J* = 7.4 Hz, 2H), 7.26--7.23 (m, 5H), 6.01 (s, 1H), 5.71 (s, 1H), 2.43 (s, 3H), 2.27--2.13 (m, 2H), 1.59--1.52 (m, 2H), 1.28 (br, 10H), 0.89 (t, *J* = 6.5 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 170.9, 143.9, 136.3, 134.6, 131.6, 129.3, 129.1, 128.8, 128.6, 128.1, 101.6, 84.7, 33.9, 31.8, 29.2, 29.1, 29.08, 24.5, 22.6, 21.6, 14.1; HRMS (ESI) *m*/*z*: calcd for C~25~H~32~INO~4~SNa^+^ (M + Na)^+^, 592.0989; found, 592.0988.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Cyclopropanecarboxylate (**4af**) {#sec3.2.8}

Yield 84% (41.7 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 137.9--138.8 °C; IR (neat, cm^--1^): 3464, 2257, 1662, 1641, 1076, 744; ^1^H NMR (400 MHz, CDCl~3~): δ 7.52 (d, *J* = 7.6 Hz, 2H), 7.36 (d, *J* = 6.9 Hz, 1H), 7.32 (d, *J* = 7.0 Hz, 2H), 7.29--7.24 (m, 5H), 6.05 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 1.54--1.51 (m, 1H), 1.07--1.06 (m, 1H), 0.95--0.90 (m, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 172.1, 143.9, 136.1, 134.5, 131.5, 129.3, 129.1, 128.9, 128.5, 128.1, 101.3, 84.8, 21.6, 12.5, 8.9, 8.7; HRMS (ESI) *m*/*z*: calcd for C~20~H~20~INO~4~SNa^+^ (M + Na)^+^, 520.0050; found, 520.0046.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Cyclobutanecarboxylate (**4ag**) {#sec3.2.9}

Yield 63% (32.2 mg); *R*~*f*~ = 0.34 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 113.9--114.6 °C; IR (neat, cm^--1^): 3433, 2936, 2383, 1635, 1363, 1166, 1085, 702; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 8.1 Hz, 2H), 7.38--7.34 (m, 1H), 7.31 (d, *J* = 7.7 Hz, 2H), 7.29--7.23 (m, 5H), 6.00 (s, 1H), 5.71 (s, 1H), 3.07--2.98 (m, 2H), 2.43 (s, 3H), 2.22--2.12 (m, 4H), 2.01--1.94 (m, 1H), 1.90--1.86 (m, 1H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 172.4, 144.0, 136.2, 134.5, 131.5, 129.3, 129.1, 128.8, 128.6, 128.1, 101.6, 84.5, 37.5, 25.0, 24.8, 21.6, 18.4; HRMS (ESI) *m*/*z*: calcd for C~21~H~22~INO~4~SNa^+^ (M + Na)^+^, 534.0206; found, 534.0208.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Cyclopentanecarboxylate (**4ah**) {#sec3.2.10}

Yield 63% (33.0 mg); *R*~*f*~ = 0.16 (SiO~2~; hexanes/ethyl acetate, 10:1); colorless liquid; IR (neat, cm^--1^): 3471, 2934, 1711, 1604, 1500, 1355, 1094, 744; ^1^H NMR (400 MHz, CDCl~3~): δ 7.54 (d, *J* = 7.5 Hz, 2H), 7.36 (d, *J* = 7.1 Hz, 1H), 7.31 (t, *J* = 7.4 Hz, 2H), 7.28--7.24 (m, 4H), 7.23 (s, 1H), 6.01 (s, 1H), 5.71 (s, 1H), 2.66--2.58 (m, 1H), 2.42 (s, 3H), 1.87--1.79 (m, 2H), 1.73--1.65 (m, 4H), 1.61--1.56 (m, 2H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 173.6, 143.9, 136.3, 134.6, 131.6, 129.3, 129.1, 128.7, 128.6, 128.1, 101.8, 84.5, 43.4, 29.8, 29.4, 25.8, 25.7, 21.6. HRMS (ESI) *m*/*z*: calcd for C~22~H~24~INO~4~SNa^+^ (M + Na)^+^, 548.03630; found, 548.0364.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Cyclohexanecarboxylate (**4ai**) {#sec3.2.11}

Yield 68% (36.6 mg); *R*~*f*~ = 0.33 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 107.5--107.9 °C; IR (neat, cm^--1^): 3458, 2378, 1678, 1641, 1270, 1080, 744; ^1^H NMR (400 MHz, CDCl~3~): δ 7.54 (d, *J* = 8.2 Hz, 2H), 7.39--7.35 (m, 1H), 7.32 (t, *J* = 7.4 Hz, 2H), 7.27--7.23 (m, 5H), 6.00 (s, 1H), 5.70 (s, 1H), 2.43 (s, 3H), 2.20--2.15 (m, 1H), 1.85--1.73 (m, 4H), 1.67--1.62 (m, 1H), 1.38--1.23 (m, 5H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 173.0, 143.9, 136.4, 134.6, 131.5, 129.3, 129.1, 128.8, 128.6, 128.1, 101.7, 84.6, 42.8, 28.8, 28.6, 25.6, 25.3, 25.26, 21.6. HRMS (ESI) *m*/*z*: calcd for C~23~H~26~INO~4~SNa^+^ (M + Na)^+^, 562.0519; found, 562.0519.

### (3*R*,5*R*,7*R*)-2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Adamantane-1-carboxylate (**4aj**) {#sec3.2.12}

Yield 63% (38.0 mg); *R*~*f*~ = 0.26 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 99.7--101.2 °C; IR (neat, cm^--1^): 3474, 2929, 2368, 1661, 1630, 1171, 1055, 743; ^1^H NMR (400 MHz, CDCl~3~): δ 7.56 (d, *J* = 8.1 Hz, 2H), 7.34--7.28 (m, 5H), 7.26--7.24 (m, 3H), 5.99 (s, 1H), 5.70 (s, 1H), 2.42 (s, 3H), 2.00 (s, 3H), 1.80--1.70 (m, 10H), 1.67 (br, 2H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 174.6, 143.9, 136.6, 134.6, 131.6, 129.4, 129.1, 128.7, 128.6, 128.1, 101.9, 84.5, 40.6, 38.7, 36.3, 27.7, 21.6. HRMS (ESI) *m*/*z*: calcd for C~27~H~30~INO~4~SNa^+^ (M + Na)^+^, 614.0832; found, 614.0836.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Benzoate (**4ak**) {#sec3.2.13}

Yield 85% (45.3 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 120.2--123.1 °C; IR (neat, cm^--1^): 3454, 2384, 1733, 1635, 1271, 1067, 707, 573; ^1^H NMR (400 MHz, CDCl~3~): δ 7.82 (d, *J* = 7.4 Hz, 2H), 7.61 (t, *J* = 7.2 Hz, 1H), 7.52--7.46 (m, 4H), 7.43 (d, *J* = 7.8 Hz, 2H), 7.40--7.36 (m, 4H), 7.03 (d, *J* = 7.9 Hz, 2H), 6.09 (s, 1H), 5.75 (s, 1H), 2.25 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 163.9, 143.9, 136.0, 134.7, 133.7, 131.5, 129.7, 129.3, 129.2, 128.7, 128.5, 128.0, 100.9, 85.8, 21.4. HRMS (ESI) *m*/*z*: calcd for C~23~H~20~INO~4~SNa^+^ (M + Na)^+^, 556.0050; found, 556.0049.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 4-Methylbenzoate (**4al**) {#sec3.2.14}

Yield 74% (40.4 mg); *R*~*f*~ = 0.29 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 141.3--142.1 °C; IR (neat, cm^--1^): 3460, 2382, 1635, 1272, 1067, 754, 580; ^1^H NMR (400 MHz, CDCl~3~): δ 7.71 (d, *J* = 7.7 Hz, 2H), 7.50 (s, 1H), 7.47 (d, *J* = 7.8 Hz, 2H), 7.42--7.34 (m, 5H), 7.24 (d, *J* = 7.5 Hz, 2H), 7.03 (d, *J* = 7.5 Hz, 2H), 6.08 (s, 1H), 5.73 (s, 1H), 2.44 (s, 3H), 2.26 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 164.0, 144.6, 143.8, 135.9, 134.7, 131.5, 129.7, 129.3, 129.2, 129.14, 129.1, 128.6, 127.9, 125.8, 101.0, 85.6, 21.8, 21.4. HRMS (ESI) *m*/*z*: calcd for C~24~H~22~INO~4~SNa^+^ (M + Na)^+^, 570.0206; found, 570.0204.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 4-Methoxybenzoate (**4am**) {#sec3.2.15}

Yield 70% (39.2 mg); *R*~*f*~ = 0.2 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 139.6--139.9 °C; IR (neat, cm^--1^): 3465, 2936, 2381, 1725, 1266, 1170, 1064, 744, 699; ^1^H NMR (400 MHz, CDCl~3~): δ 7.78 (d, *J* = 8.0 Hz, 2H), 7.48--7.46 (m, 3H), 7.38--7.35 (m, 5H), 7.04 (d, *J* = 7.8 Hz, 2H), 6.91 (d, *J* = 8.0 Hz, 2H), 6.08 (s, 1H), 5.73 (s, 1H), 3.89 (s, 3H), 2.27 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 163.9, 163.6, 143.8, 136.0, 134.7, 131.8, 131.5, 129.3, 129.1, 129.07, 128.6, 128.0, 120.9, 113.7, 101.2, 85.5, 55.5, 21.5. HRMS (ESI) *m*/*z*: calcd for C~24~H~22~INO~4~SNa^+^ (M + Na)^+^, 586.0161; found, 586.0170.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 4-Fluorobenzoate (**4an**) {#sec3.2.16}

Yield 68% (37.6 mg); *R*~*f*~ = 0.4 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 115.9--116.3 °C; IR (neat, cm^--1^): 3434, 3143, 1625, 1406, 1069, 575, 476; ^1^H NMR (400 MHz, CDCl~3~): δ 7.87 (d, *J* = 5.4 Hz, 1H), 7.84 (d, *J* = 5.4 Hz, 1H), 7.49 (s, 2H), 7.47 (s, 1H), 7.40--7.32 (m, 5H), 7.12 (t, *J* = 8.6 Hz, 2H), 7.06 (d, *J* = 8.2 Hz, 2H), 6.08 (t, *J* = 1.9 Hz, 1H), 5.75 (s, 1H), 2.29 (s, 3H). ^13^C{^1^H} NMR (101 MHz, CDCl~3~): δ 166.1 (d, *J* = 254.3 Hz), 163.0, 143.9, 136.0, 134.6, 132.3 (d, *J* = 9.4 Hz), 131.5, 129.3, 129.24, 129.2, 128.7, 128.0, 124.9 (d, *J* = 3.0 Hz), 115.8 (d, *J* = 22.0 Hz), 100.8, 85.9, 21.4. HRMS (ESI) *m*/*z*: calcd for C~23~H~19~FINO~4~SNa^+^ (M + Na)^+^, 573.9956; found, 573.9958.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 4-Chlorobenzoate (**4ao**) {#sec3.2.17}

Yield 65% (36.7 mg); *R*~*f*~ = 0.38 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 98.3--99.7 °C; IR (neat, cm^--1^): 3465, 2276, 1660, 1648, 1271, 1059, 744, 707; ^1^H NMR (400 MHz, CDCl~3~): δ 7.77 (d, *J* = 8.5 Hz, 2H), 7.49 (s, 2H), 7.47 (s, 1H), 7.44--7.43 (m, 1H), 7.42--7.40 (m, 1H), 7.39--7.38 (m, 1H), 7.36 (s, 1H), 7.35--7.31 (m, 3H), 7.06 (d, *J* = 8.2 Hz, 2H), 6.08 (s, 1H), 5.75 (s, 1H), 2.29 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 163.1, 144.0, 140.3, 136.0, 134.6, 131.5, 131.0, 129.3, 129.2, 128.9, 128.7, 128.0, 127.1, 100.7, 86.0, 21.4. HRMS (ESI) *m*/*z*: calcd for C~23~H~19~ClINO~4~SNa^+^ (M + Na)^+^, 589.9660; found, 589.9664.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 4-Bromobenzoate (**4ap**) {#sec3.2.18}

Yield 69% (41.9 mg); *R*~*f*~ = 0.33 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 112.1--112.8 °C; IR (neat, cm^--1^): 3464, 2286, 1647, 1271, 1070, 745, 706; ^1^H NMR (400 MHz, CDCl~3~): δ 7.68 (d, *J* = 8.4 Hz, 2H), 7.59 (d, *J* = 7.5 Hz, 2H), 7.49 (s, 2H), 7.47 (s, 1H), 7.42--7.31 (m, 5H), 7.06 (d, *J* = 7.7 Hz, 2H), 6.07 (s, 1H), 5.76 (s, 1H), 2.29 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 163.3, 144.0, 135.9, 134.5, 131.9, 131.4, 131.1, 129.3, 129.27, 129.25, 128.9, 128.7, 127.9, 127.5, 100.6, 86.0, 21.5. HRMS (ESI) *m*/*z*: calcd for C~23~H~19~BrINO~4~SNa^+^ (M + Na)^+^, 633.9155; found, 633.9157.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 2-Methylbenzoate (**4aq**) {#sec3.2.19}

Yield 68% (37.0 mg); *R*~*f*~ = 0.38 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 96.6--96.9 °C; IR (neat, cm^--1^): 3456, 2935, 2383, 1635, 1049, 754, 702; ^1^H NMR (400 MHz, CDCl~3~): δ 7.51 (d, *J* = 7.8 Hz, 2H), 7.47--7.43 (m, 3H), 7.40--7.33 (m, 5H), 7.29 (d, *J* = 7.2 Hz, 1H), 7.18 (t, *J* = 7.2 Hz, 1H), 7.09 (d, *J* = 7.5 Hz, 2H), 6.11 (s, 1H), 5.75 (s, 1H), 2.63 (s, 3H), 2.30 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 164.3, 143.9, 141.6, 136.1, 134.7, 132.7, 132.0, 131.5, 130.1, 129.3, 129.1, 129.09, 128.6, 127.9, 127.5, 125.6, 101.3, 85.6, 21.8, 21.5. HRMS (ESI) *m*/*z*: calcd for C~24~H~22~INO~4~SNa^+^ (M + Na)^+^, 570.0206; found, 570.0205.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 3-Fluorobenzoate (**4ar**) {#sec3.2.20}

Yield 68% (37.4 mg); *R*~*f*~ = 0.31 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 92.1--92.7 °C; IR (neat, cm^--1^): 3453, 2928, 2375, 1633, 1081, 756; ^1^H NMR (400 MHz, CDCl~3~): δ 7.66 (d, *J* = 7.7 Hz, 1H), 7.49 (s, 2H), 7.47 (s, 1H), 7.44--7.39 (m, 4H), 7.37--7.30 (m, 5H), 7.07 (d, *J* = 7.9 Hz, 2H), 6.07 (s, 1H), 5.76 (s, 1H), 2.29 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 162.9, 162.8, 162.4 (d, *J* = 246.5 Hz), 144.1, 135.9, 134.5, 131.5, 130.3, 130.2, 129.4, 129.3 (d, *J* = 2.4 Hz), 128.7, 127.9, 125.5 (d, *J* = 3.1 Hz), 120.8 (d, *J* = 21.2 Hz), 116.4 (d, *J* = 23.1 Hz), 100.5, 86.2, 21.4. HRMS (ESI) *m*/*z*: calcd for C~23~H~19~FINO~4~SNa^+^ (M + Na)^+^, 573.9956; found, 573.9959.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 2-Naphthoate (**4as**) {#sec3.2.21}

Yield 72% (41.4 mg); *R*~*f*~ = 0.24 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 121.8--122.3 °C; IR (neat, cm^--1^): 3452, 2928, 2366, 1634, 1025, 724, 668; ^1^H NMR (400 MHz, CDCl~3~): δ 8.30 (s, 1H), 7.91--7.86 (m, 3H), 7.82 (d, *J* = 8.5 Hz, 1H), 7.64 (t, *J* = 7.3 Hz, 1H), 7.59 (d, *J* = 7.5 Hz, 1H), 7.56 (s, 1H), 7.48 (d, *J* = 8.0 Hz, 2H), 7.44--7.38 (m, 5H), 6.97 (d, *J* = 7.9 Hz, 2H), 6.14 (s, 1H), 5.76 (s, 1H), 2.08 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 164.1, 143.9, 136.0, 135.7, 134.7, 132.2, 131.5, 131.46, 129.32, 129.3, 129.2, 129.2, 128.8, 128.7, 128.3, 127.9, 127.8, 126.9, 125.8, 124.9, 100.9, 86.0, 21.3. HRMS (ESI) *m*/*z*: calcd for C~27~H~22~INO~4~SNa^+^ (M + Na)^+^, 606.0206; found, 606.0207.

### 2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl Cinnamate (**4at**) {#sec3.2.22}

Yield 69% (38.5 mg); *R*~*f*~ = 0.36 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 134.0--135.2 °C; IR (neat, cm^--1^): 3462, 2936, 2382, 1758, 1634, 1366, 1215, 1013, 716; ^1^H NMR (400 MHz, CDCl~3~): δ 7.56 (d, *J* = 16.0 Hz, 1H), 7.51--7.49 (m, 4H), 7.43--7.41 (m, 3H), 7.38--7.36 (m, 2H), 7.35--7.31 (m, 4H), 7.15 (d, *J* = 7.9 Hz, 2H), 6.25 (d, *J* = 16.0 Hz, 1H), 6.08 (s, 1H), 5.73 (s, 1H), 2.27 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 164.1, 146.6, 143.9, 136.0, 134.6, 133.7, 131.5, 130.9, 129.3, 129.1, 129.0, 128.6, 128.2, 128.1, 116.2, 101.0, 85.3, 21.4. HRMS (ESI) *m*/*z*: calcd for C~25~H~22~INO~4~SNa^+^ (M + Na)^+^, 582.0206; found, 582.0208.

### 2-Iodo-1-(4-methyl-*N*-(*p*-tolyl)phenylsulfonamido)allyl Acetate (**4ba**) {#sec3.2.23}

Yield 89% (43.0 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 112.3--113.4 °C; IR (neat, cm^--1^): 3463, 2934, 2382, 1755, 1635, 1217, 1087, 744; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 7.7 Hz, 2H), 7.26 (s, 2H), 7.24 (s, 1H), 7.10 (br, 4H), 6.03 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 2.35 (s, 3H), 1.98 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 143.9, 139.2, 136.1, 131.7, 131.1, 129.2, 128.8, 128.1, 101.3, 84.9, 21.6, 21.2, 20.5. HRMS (ESI) *m*/*z*: calcd for C~19~H~20~INO~4~SNa^+^ (M + Na)^+^, 508.0050; found, 508.0048.

### 2-Iodo-1-(*N*-(4-methoxyphenyl)-4-methylphenylsulfonamido)allyl Acetate (**4ca**) {#sec3.2.24}

Yield 81% (40.6 mg); *R*~*f*~ = 0.2 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 142.1--142.3 °C; IR (neat, cm^--1^): 3469, 2384, 1634, 1270, 1072, 749; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 5.2 Hz, 2H), 7.25 (d, *J* = 7.2 Hz, 4H), 7.14 (d, *J* = 6.3 Hz, 1H), 6.80 (d, *J* = 7.2 Hz, 2H), 6.03 (s, 1H), 5.74 (s, 1H), 3.81 (s, 3H), 2.44 (s, 3H), 1.99 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 159.9, 143.9, 136.1, 132.7, 129.3, 128.8, 128.1, 126.9, 113.7, 101.5, 85.0, 55.3, 21.6, 20.6. HRMS (ESI) *m*/*z*: calcd for C~19~H~20~INO~5~SNa^+^ (M + Na)^+^, 523.9999; found, 523.9996.

### 1-(*N*-(4-Fluorophenyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4da**) {#sec3.2.25}

Yield 66% (32.4 mg); *R*~*f*~ = 0.22 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 108.2--109.4 °C; IR (neat, cm^--1^): 3468, 2965, 2376, 1660, 1213, 1011, 740; ^1^H NMR (400 MHz, CDCl~3~): δ 7.52 (d, *J* = 8.1 Hz, 2H), 7.27 (d, *J* = 2.8 Hz, 2H), 7.26--7.22 (m, 3H), 7.21 (d, *J* = 5.0 Hz, 1H), 6.99 (t, *J* = 8.5 Hz, 2H), 6.04 (s, 1H), 5.75 (s, 1H), 2.44 (s, 3H), 2.00 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.0, 162.7 (d, *J* = 248.3 Hz), 144.3, 135.8, 133.3 (d, *J* = 8.8 Hz), 130.3 (d, *J* = 3.2 Hz), 129.4, 129.0, 128.0, 115.6 (d, *J* = 22.5 Hz), 101.1, 84.8, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~18~H~17~FINO~4~SNa^+^ (M + Na)^+^, 511.9799; found, 511.9798.

### 1-(*N*-(4-Chlorophenyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4ea**) {#sec3.2.26}

Yield 73% (36.9 mg); *R*~*f*~ = 0.24 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 129.3--130.7 °C; IR (neat, cm^--1^): 3448, 2932, 2378, 1643, 1273, 1014, 752; ^1^H NMR (400 MHz, CDCl~3~): δ 7.44 (d, *J* = 8.0 Hz, 2H), 7.22--7.16 (m, 5H), 7.11 (d, *J* = 8.5 Hz, 2H), 5.98 (s, 1H), 5.67 (s, 1H), 2.37 (s, 3H), 1.91 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 144.3, 135.7, 135.2, 133.0, 132.6, 129.4, 129.1, 128.8, 128.0, 100.9, 84.8, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~18~H~17~ClINO~4~SNa^+^ (M + Na)^+^, 527.9503; found, 527.9506.

### 1-(*N*-(4-Bromophenyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4fa**) {#sec3.2.27}

Yield 71% (39.0 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 145.6--145.9 °C; IR (neat, cm^--1^): 3475, 1936, 2368, 1758, 1636, 1216, 1013, 753; ^1^H NMR (400 MHz, CDCl~3~): δ 7.52 (d, *J* = 8.2 Hz, 2H), 7.43 (d, *J* = 8.5 Hz, 2H), 7.27 (d, *J* = 3.0 Hz, 1H), 7.25 (d, *J* = 8.3 Hz, 2H), 7.12 (d, *J* = 8.5 Hz, 2H), 6.05 (s, 1H), 5.75 (s, 1H), 2.44 (s, 3H), 1.99 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 144.3, 135.7, 133.6, 133.0, 131.9, 129.4, 129.2, 128.0, 123.5, 100.9, 84.7, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~18~H~17~BrINO~4~SNa^+^ (M + Na)^+^, 571.8999; found, 571.8998.

### 2-Iodo-1-(*N*-(3-methoxyphenyl)-4-methylphenylsulfonamido)allyl Acetate (**4ga**) {#sec3.2.28}

Yield 72% (36.0 mg); *R*~*f*~ = 0.2 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 114.8--115.9 °C; IR (neat, cm^--1^): 3458, 2935, 2388, 1617, 1172, 1087, 752, 569; ^1^H NMR (400 MHz, CDCl~3~): δ 7.55 (d, *J* = 5.4 Hz, 2H), 7.29--7.17 (m, 4H), 6.91 (d, *J* = 5.7 Hz, 1H), 6.83 (s, 2H), 6.05 (s, 1H), 5.73 (s, 1H), 3.76 (s, 3H), 2.44 (s, 3H), 1.98 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 159.3, 144.1, 136.0, 135.5, 129.3, 128.9, 128.1, 123.5, 117.3, 114.8, 100.9, 84.9, 55.3, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~19~H~20~INO~5~SNa^+^ (M + Na)^+^, 523.9999; found, 523.9998.

### 1-(*N*-(3-Bromophenyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4ha**) {#sec3.2.29}

Yield 62% (34.1 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 144.9--145.7 °C; IR (neat, cm^--1^): 3466, 2377, 4642, 1272, 745; ^1^H NMR (400 MHz, CDCl~3~): δ 7.54 (d, *J* = 8.2 Hz, 2H), 7.50 (d, *J* = 8.1 Hz, 1H), 7.39 (s, 1H), 7.29 (d, *J* = 8.0 Hz, 2H), 7.24--7.16 (m, 3H), 6.08 (s, 1H), 5.77 (s, 1H), 2.45 (s, 3H), 2.00 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 144.4, 135.8, 135.6, 134.4, 132.3, 130.1, 129.7, 129.4, 129.2, 128.0, 121.6, 100.7, 84.7, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~18~H~17~BrINO~4~SNa^+^ (M + Na)^+^, 571.8998; found, 571.9004.

### 1-(*N*-(3,5-Dimethoxyphenyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4ia**) {#sec3.2.30}

Yield 72% (38.3 mg); *R*~*f*~ = 0.10 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 81.5--82.3 °C; IR (neat, cm^--1^): 3457, 2968, 2834, 1629, 1438, 1168, 1085, 772; ^1^H NMR (400 MHz, CDCl~3~): δ 7.59 (d, *J* = 8.0 Hz, 2H), 7.28 (d, *J* = 5.5 Hz, 2H), 7.21 (s, 1H), 6.46 (s, 1H), 6.42 (s, 2H), 6.08 (s, 1H), 5.76 (s, 1H), 3.73 (s, 6H), 2.44 (s, 3H), 1.96 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 160.0, 144.1, 136.1, 136.0, 129.3, 129.1, 128.1, 109.8, 101.1, 100.8, 84.9, 55.4, 21.6, 20.5. HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~6~SNa^+^ (M + Na)^+^, 554.0105; found, 554.0108.

### 2-Iodo-1-(4-methyl-*N*-(naphthalen-2-yl)phenylsulfonamido)allyl Acetate (**4ja**) {#sec3.2.31}

Yield 78% (40.5 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 123.3--125.2 °C; IR (neat, cm^--1^): 3456, 2924, 2384, 1643, 1272, 1084, 752; ^1^H NMR (400 MHz, CDCl~3~): δ 7.85 (d, *J* = 7.3 Hz, 1H), 7.80 (d, *J* = 7.5 Hz, 1H), 7.76 (d, *J* = 9.9 Hz, 2H), 7.54--7.49 (m, 4H), 7.34 (br, 2H), 7.25 (d, *J* = 8.2 Hz, 2H), 6.03 (s, 1H), 5.66 (s, 1H), 2.45 (s, 3H), 2.04 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 144.1, 136.1, 133.1, 132.9, 131.9, 130.8, 129.3, 129.0, 128.6, 128.4, 128.3, 128.1, 127.6, 127.1, 126.3, 101.0, 85.2, 21.6, 20.7. HRMS (ESI) *m*/*z*: calcd for C~22~H~20~INO~4~SNa^+^ (M + Na)^+^, 544.0050; found, 544.0046.

### 1-(*N*-Benzyl-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4ka**) {#sec3.2.32}

Yield 69% (33.4 mg); *R*~*f*~ = 0.24 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 86.9--88.9 °C; IR (neat, cm^--1^): 3463, 2968, 2374, 1662, 1164, 1056, 738; ^1^H NMR (400 MHz, CDCl~3~): δ 7.61 (d, *J* = 8.2 Hz, 2H), 7.34--7.31 (m, 2H), 7.24--7.22 (m, 5H), 6.90 (s, 1H), 6.37 (s, 1H), 5.98 (s, 1H), 4.51 (d, *J* = 15.9 Hz, 1H), 4.40 (d, *J* = 15.9 Hz, 1H), 2.41 (s, 3H), 1.84 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 143.8, 136.5, 136.3, 129.4, 129.2, 128.9, 128.0, 127.8, 127.4, 102.5, 84.7, 48.0, 21.5, 20.3. HRMS (ESI) *m*/*z*: calcd for C~19~H~20~INO~4~SNa^+^ (M + Na)^+^, 508.0050; found, 508.0052.

### 1-(*N*-Benzyl-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4la**) {#sec3.2.33}

Yield 91% (45.6 mg); *R*~*f*~ = 0.35 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 109.9--110.5 °C; IR (neat, cm^--1^): 3439, 2965, 2385, 1756, 1634, 1165, 1101, 744; ^1^H NMR (400 MHz, CDCl~3~): δ 7.61 (d, *J* = 8.0 Hz, 2H), 7.25--7.18 (m, 4H), 7.05 (d, *J* = 7.5 Hz, 2H), 6.89 (s, 1H), 6.38 (s, 1H), 5.98 (s, 1H), 4.46 (d, *J* = 15.8 Hz, 1H), 4.35 (d, *J* = 15.9 Hz, 1H), 2.41 (s, 3H), 2.32 (s, 3H), 1.85 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 143.7, 137.0, 136.5, 133.1, 129.4, 129.2, 128.9, 128.6, 127.8, 102.6, 84.7, 47.8, 21.5, 21.1, 20.3. HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~4~SNa^+^ (M + Na)^+^, 522.0206; found, 522.0208.

### 2-Iodo-1-(*N*-(4-methoxybenzyl)-4-methylphenylsulfonamido)allyl Acetate (**4ma**) {#sec3.2.34}

Yield 67% (35.0 mg); *R*~*f*~ = 0.16 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 114.2--116.2 °C; IR (neat, cm^--1^): 3469, 2939, 2383, 1629, 1166, 1028, 756, 669; ^1^H NMR (400 MHz, CDCl~3~): δ 7.52 (d, *J* = 7.9 Hz, 2H), 7.18 (d, *J* = 4.4 Hz, 1H), 7.15 (d, *J* = 7.3 Hz, 3H), 6.81 (s, 1H), 6.69 (d, *J* = 8.2 Hz, 2H), 6.30 (s, 1H), 5.91 (s, 1H), 4.36 (d, *J* = 15.6 Hz, 1H), 4.27 (d, *J* = 15.7 Hz, 1H), 3.72 (s, 3H), 2.33 (s, 3H), 1.79 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 159.0, 143.7, 136.6, 130.4, 129.3, 129.1, 128.2, 127.7, 113.3, 102.7, 84.7, 55.2, 47.5, 21.5, 20.3. HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~5~SNa^+^ (M + Na)^+^, 538.0156; found, 538.0159.

### 1-(*N*-(4-Fluorobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4na**) {#sec3.2.35}

Yield 68% (34.2 mg); *R*~*f*~ = 0.18 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 58.4--59.6 °C; IR (neat, cm^--1^): 3458, 2382, 1635, 1273, 1056, 752; ^1^H NMR (400 MHz, CDCl~3~): δ 7.61 (d, *J* = 8.1 Hz, 2H), 7.34--7.30 (m, 2H), 7.26 (s, 1H), 7.24 (s, 1H), 6.93 (t, *J* = 8.6 Hz, 2H), 6.88 (s, 1H), 6.37 (s, 1H), 5.97 (s, 1H), 4.44 (d, *J* = 15.9 Hz, 1H), 4.38 (d, *J* = 15.9 Hz, 1H), 2.41 (s, 3H), 1.85 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 162.1 (d, *J* = 244.6 Hz), 143.9, 136.3, 132.0 (d, *J* = 3.2 Hz), 131.0, 130.7, 129.4, 129.2, 127.6 (d, *J* = 12.5 Hz), 114.9, 114.7, 102.5, 84.6, 47.2, 21.5, 20.2. HRMS (ESI) *m*/*z*: calcd for C~19~H~19~FINO~4~SNa^+^ (M + Na)^+^, 525.9956; found, 525.9959.

### 1-(*N*-(4-Chlorobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4oa**) {#sec3.2.36}

Yield 62% (32 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 135.6--136.2 °C; IR (neat, cm^--1^): 3458, 2937, 2383, 1653, 1363, 1166, 1061, 1016, 822, 745; ^1^H NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 8.0 Hz, 2H), 7.29 (d, *J* = 8.1 Hz, 2H), 7.19--7.13 (m, 4H), 6.82 (s, 1H), 6.30 (s, 1H), 5.91 (s, 1H), 4.35 (d, *J* = 16.0 Hz, 1H), 4.27 (d, *J* = 16.0 Hz, 1H), 2.35 (s, 3H), 1.79 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 144.1, 136.2, 135.4, 131.0, 130.6, 129.5, 129.3, 127.7, 121.4, 102.3, 84.7, 47.3, 21.5, 20.3. HRMS (ESI) *m*/*z*: calcd for C~19~H~19~ClINO~4~SNa^+^ (M + Na)^+^, 541.9660; found, 541.9660.

### 1-(*N*-(4-Bromobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4pa**) {#sec3.2.37}

Yield 84% (47.1 mg); *R*~*f*~ = 0.21 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 112.7--114.6 °C; IR (neat, cm^--1^): 3457, 2936, 2835, 1758, 1361, 1165, 745, 699; ^1^H NMR (400 MHz, CDCl~3~): δ 7.61 (d, *J* = 8.0 Hz, 2H), 7.37 (d, *J* = 8.1 Hz, 2H), 7.26--7.20 (m, 4H), 6.89 (s, 1H), 6.38 (s, 1H), 5.98 (s, 1H), 4.43 (d, *J* = 16.0 Hz, 1H), 4.35 (d, *J* = 16.1 Hz, 1H), 2.43 (s, 3H), 1.87 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 167.9, 144.1, 136.2, 135.4, 131.1, 130.6, 129.5, 129.3, 127.7, 121.4, 102.4, 84.7, 47.3, 21.5, 20.3. HRMS (ESI) *m*/*z*: calcd for C~19~H~19~BrINO~4~SNa^+^ (M + Na)^+^, 581.9135; found, 581.9145.

### 2-Iodo-1-(4-methyl-*N*-phenethylphenylsulfonamido)allyl Acetate (**4qa**) {#sec3.2.38}

Yield 72% (36.1 mg); *R*~*f*~ = 0.35 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 81.5--82.4 °C; IR (neat, cm^--1^): 3457, 2383, 1755, 1635, 1272, 1166, 756; ^1^H NMR (400 MHz, CDCl~3~): δ 7.76 (d, *J* = 7.6 Hz, 2H), 7.29 (t, *J* = 7.1 Hz, 4H), 7.23 (d, *J* = 6.9 Hz, 1H), 7.16 (d, *J* = 7.4 Hz, 2H), 6.87 (s, 1H), 6.51 (s, 1H), 6.14 (s, 1H), 3.43--3.29 (m, 2H), 3.07--2.96 (m, 2H), 2.42 (s, 3H), 1.91 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.1, 144.0, 138.7, 136.2, 129.6, 128.7, 128.69, 128.6, 127.7, 126.5, 102.9, 84.7, 46.2, 37.3, 21.5, 20.4. HRMS (ESI) *m*/*z*: calcd for C~20~H~22~INO~4~SNa^+^ (M + Na)^+^, 522.0206; found, 522.0208.

### 1-(*N*-Butyl-4-methylphenylsulfonamido)-2-iodoallyl Acetate (**4ra**) {#sec3.2.39}

Yield 48% (21.7 mg); *R*~*f*~ = 0.28 (SiO~2~; hexanes/ethyl acetate, 10:1); yellow liquid; IR (neat, cm^--1^): 3466, 2991, 2389, 1644, 1164, 752; ^1^H NMR (400 MHz, CDCl~3~): δ 7.66 (d, *J* = 7.9 Hz, 2H), 7.23 (d, *J* = 7.9 Hz, 2H), 6.75 (s, 1H), 6.37 (s, 1H), 5.98 (s, 1H), 3.18--3.11 (m, 1H), 3.06--2.98 (m, 1H), 2.36 (s, 3H), 1.85 (s, 3H), 1.64--1.52 (m, 2H), 1.24--1.14 (m, 2H), 0.82 (t, *J* = 7.3 Hz, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.2, 143.8, 136.4, 129.5, 128.5, 127.7, 102.8, 84.7, 44.4, 32.5, 21.5, 20.4, 20.2, 13.6. HRMS (ESI) *m*/*z*: calcd for C~16~H~22~INO~4~SNa^+^ (M + Na)^+^, 474.0206; found, 474.0207.

### 2-Iodo-1-(*N*-phenylmethylsulfonamido)allyl Acetate (**4sa**) {#sec3.2.40}

Yield 74% (29.3 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 113.1--114.4 °C; IR (neat, cm^--1^): 3760, 3448, 2939, 2384, 1756, 1653, 1216, 1020, 746, 701; ^1^H NMR (400 MHz, CDCl~3~): δ 7.51--7.47 (m, 2H), 7.42--7.40 (m, 3H), 7.12 (s, 1H), 6.14 (s, 1H), 5.80 (s, 1H), 3.04 (s, 3H), 2.23 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.2, 134.2, 131.2, 129.5, 129.2, 129.0, 101.2, 85.1, 39.9, 20.8. HRMS (ESI) *m*/*z*: calcd for C~12~H~14~INO~4~Na^+^ (M + Na)^+^, 417.9580; found, 417.9592.

### 2-Iodo-1-(*N*-phenylacetamido)allyl Acetate (**4ta**) {#sec3.2.41}

Yield 81% (29.0 mg); *R*~*f*~ = 0.13 (SiO~2~; hexanes/ethyl acetate, 10:1); brown liquid; IR (neat, cm^--1^): 3460, 2934, 2380, 1687, 1272, 1219, 1096, 1014, 823, 705; ^1^H NMR (400 MHz, CDCl~3~): δ 7.64 (s, 1H), 7.41 (s, 3H), 7.33 (s, 2H), 6.13 (s, 1H), 5.81 (s, 1H), 2.15 (s, 3H), 1.88 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.2, 168.1, 137.6, 129.9, 129.1, 128.9, 128.4, 102.4, 80.3, 23.2, 20.7. HRMS (ESI) *m*/*z*: calcd for C~13~H~14~INO~3~Na^+^ (M + Na)^+^, 381.9911; found, 381.9914.

### 2-Iodo-1-(2-oxooxazolidin-3-yl)allyl Acetate (**4ua**) {#sec3.2.42}

Yield 48% (15.1 mg); *R*~*f*~ = 0.1 (SiO~2~; hexanes/ethyl acetate, 10:1); colorless liquid; IR (neat, cm^--1^): 2354, 2934, 2384, 1751, 1652, 1422, 1258, 1038, 927, 757; ^1^H NMR (400 MHz, CDCl~3~): δ 6.76 (s, 1H), 6.55 (s, 1H), 6.12 (s, 1H), 4.41 (t, *J* = 7.7 Hz, 2H), 3.60 (t, *J* = 7.8 Hz, 2H), 2.16 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 168.0, 156.8, 128.7, 101.3, 80.6, 62.5, 39.9, 20.5. HRMS (ESI) *m*/*z*: calcd for C~8~H~10~INO~4~Na^+^ (M + Na)^+^, 333.9547; found, 333.9542.

### (*Z*)-2-Iodo-3-(*N*-mesityl-4-methylphenylsulfonamido)allyl Acetate (**5**) {#sec3.2.43}

Yield 56% (28.6 mg); *R*~*f*~ = 0.26 (SiO~2~; hexanes/ethyl acetate, 10:1); white solid; mp 132.9--133.6 °C; IR (neat, cm^--1^): 3454, 2937, 2382, 1625, 1088, 757; ^1^H NMR (400 MHz, CDCl~3~): δ 7.60 (d, *J* = 8.0 Hz, 2H), 7.56 (s, 1H), 7.31 (d, *J* = 7.9 Hz, 2H), 6.84 (s, 2H), 4.83 (s, 2H), 2.45 (s, 3H), 2.29 (s, 3H), 2.07 (s, 3H), 1.82 (s, 6H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 170.5, 144.6, 140.3, 139.6, 135.9, 133.0, 129.9, 129.5, 129.2, 128.9, 127.9, 73.6, 67.9, 21.6, 21.1, 21.0, 19.1. HRMS (ESI) *m*/*z*: calcd for C~21~H~24~INO~4~SNa^+^ (M + Na)^+^, 536.0363; found, 536.0366.

### (2*S*)-2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 2-((*tert*-Butoxycarbonyl)amino)-3-phenylpropanoate (**6**, dr = 1:1) {#sec3.2.44}

Yield 51% (34.4 mg); *R*~*f*~ = 0.2 (SiO~2~; hexanes/ethyl acetate, 10:1); colorless liquid; IR (neat, cm^--1^): 3438, 2991, 1718, 1500, 1368, 1169, 1084, 703, 666; ^1^H NMR (400 MHz, CDCl~3~): δ 7.57 (d, *J* = 7.6 Hz, 2H), 7.43 (d, *J* = 7.6 Hz, 2H), 7.34--7.26 (m, 12H), 7.23 (d, *J* = 5.1 Hz, 6H), 7.15 (t, *J* = 7.3 Hz, 6H), 5.99 (s, 1H), 5.85 (s, 1H), 5.67 (s, 1H), 5.65 (s, 1H), 5.30 (s, 2H), 4.85 (d, *J* = 7.9 Hz, 1H), 4.76 (d, *J* = 7.9 Hz, 1H), 4.49 (s, 2H), 3.14--3.05 (m, 2H), 3.04--2.96 (m, 2H), 2.41 (s, 3H), 2.39 (s, 3H), 1.43 (s, 9H), 1.36 (s, 9H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 169.9, 169.7, 154.9, 144.3, 144.2, 136.0, 135.8, 135.7, 135.6, 134.2, 131.5, 131.48, 129.9, 129.8, 129.5, 129.43, 129.4, 129.3, 129.2, 129.1, 128.8, 128.7, 128.69, 128.6, 128.2, 128.1, 127.2, 127.1, 99.9, 99.8, 86.1, 86.0, 80.2, 60.4, 54.2, 53.9, 53.5, 37.8, 37.6, 28.3, 28.2, 21.7, 21.6, 14.2. HRMS (ESI) *m*/*z*: calcd for C~30~H~33~IN~2~O~6~SNa^+^ (M + Na)^+^, 699.0996; found, 699.1002.

### (2*S*)-2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 2-Acetamido-3-phenylpropanoate (**7**, dr = 1:1) {#sec3.2.45}

Yield 47% (28.8 mg); *R*~*f*~ = 0.25 (SiO~2~; hexanes/ethyl acetate, 3:1); yellow liquid; IR (neat, cm^--1^): 3403, 3303, 3075, 1760, 1688, 1500, 1082, 714, 703; ^1^H NMR (400 MHz, CDCl~3~): δ 7.59 (d, *J* = 8.0 Hz, 2H), 7.41 (d, *J* = 7.8 Hz, 2H), 7.37--7.30 (m, 4H), 7.30--7.22 (m, 12H), 7.17 (t, *J* = 7.5 Hz, 4H), 7.14--7.07 (m, 4H), 6.08--6.00 (m, 3H), 5.77 (s, 1H), 5.68 (s, 1H), 5.62 (s, 1H), 5.27 (s, 1H), 4.79 (dt, *J* = 14.4, 7.2 Hz, 2H), 3.13 (dd, *J* = 14.2, 5.2 Hz, 1H), 3.05 (d, *J* = 6.3 Hz, 2H), 3.02--2.97 (m, 1H), 2.40 (s, 3H), 2.37 (s, 3H), 1.95 (s, 3H), 1.88 (s, 3H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 170.1, 169.9, 169.7, 169.6, 144.4, 144.3, 135.9, 135.6, 135.5, 135.4, 134.1, 133.99, 131.6, 131.4, 130.0, 129.5, 129.4, 129.3, 129.29, 129.25, 129.2, 128.84, 128.8, 128.7, 128.6, 128.2, 128.1, 127.32, 127.3, 99.8, 99.5, 86.3, 86.2, 62.8, 52.9, 52.6, 37.4, 37.2, 22.9, 22.8, 21.7. HRMS (ESI) *m*/*z*: calcd for C~27~H~27~IN~2~O~5~SNa^+^ (M + Na)^+^, 641.0578; found, 641.0575.

### (2*S*)-2-Iodo-1-(4-methyl-*N*-phenylphenylsulfonamido)allyl 2-((*tert*-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoate (**8**, dr = 1:1) {#sec3.2.46}

Yield 51% (35.4 mg); *R*~*f*~ = 0.2 (SiO~2~; hexanes/ethyl acetate, 3:1); colorless liquid; IR (neat, cm^--1^): 3402, 2991, 1700, 1520, 1168, 1068, 736, 701; ^1^H NMR (400 MHz, CDCl~3~): δ 7.56 (d, *J* = 7.8 Hz, 2H), 7.43 (d, *J* = 7.7 Hz, 2H), 7.33--7.30 (m, 3H), 7.26 (d, *J* = 7.5 Hz, 4H), 7.23--7.11 (m, 8H), 7.05 (d, *J* = 7.8 Hz, 2H), 6.98 (d, *J* = 7.8 Hz, 2H), 6.79--6.70 (m, 4H), 6.02 (br, 1H), 5.99 (s, 1H), 5.87 (s, 1H), 5.65 (s, 2H), 4.91--4.84 (m, 2H), 4.46--4.41 (m, 2H), 3.03--2.96 (m, 2H), 2.94--2.88 (m, 2H), 2.39 (s, 3H), 2.37 (s, 3H), 1.41 (s, 9H), 1.35 (s, 9H). ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 170.0, 169.8, 155.1, 144.3, 144.28, 135.9, 135.8, 134.1, 131.6, 131.5, 130.5, 130.4, 130.0, 129.9, 129.6, 129.5, 129.4, 129.3, 129.2, 128.7, 128.6, 128.2, 128.1, 127.9, 127.8, 127.3, 127.23, 127.2, 121.7, 115.7, 99.9, 99.8, 86.1, 80.3, 60.5, 54.4, 54.2, 37.1, 36.8, 28.3, 28.2, 21.6, 21.58, 14.1. HRMS (ESI) *m*/*z*: calcd for C~30~H~33~IN~2~O~7~SNa^+^ (M + Na)^+^, 715.0945; found, 715.0949.
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